Inactive Instrument

Highlights Nivalis Therapeutics Inc Nasdaq

Equities

US65481J1097

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	May. 10	MT
Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	May. 09	RE
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug	May. 06	DJ
Health Care Slips on Risk Bias -- Health Care Roundup	Apr. 11	DJ
Global markets live: Airbus, UBS, KKR, Meta Platforms, Tesla...	Apr. 11
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	Apr. 11	MT
Sector Update: Health Care	Apr. 11	MT
Top Premarket Gainers	Apr. 11	MT
Vertex Pharmaceuticals' $4.9 Billion Deal for Alpine Shows Lead-Candidate's Potential, Analysts Say	Apr. 11	MT
News Highlights : Top Company News of the Day - Thursday at 7 AM ET	Apr. 11	DJ
News Highlights : Top Company News of the Day - Thursday at 5 AM ET	Apr. 11	DJ
News Highlights : Top Company News of the Day - Thursday at 3 AM ET	Apr. 11	DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	Apr. 11	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET	Apr. 10	DJ
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET	Apr. 10	DJ
Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.	Apr. 10	DJ
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update	Apr. 10	DJ
News Highlights : Top Company News of the Day - Wednesday at 5 PM ET	Apr. 10	DJ
News Highlights : Top Company News of the Day - Wednesday at 7 PM ET	Apr. 10	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nivalis Therapeutics Inc Nasdaq

Equities

US65481J1097

Highlights

Filters